Hepatic Encephalopathy
170
17
21
77
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
17 trials with published results (10%)
Research Maturity
77 completed trials (45% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
7.6%
13 terminated out of 170 trials
85.6%
-1.0% vs benchmark
26%
44 trials in Phase 3/4
22%
17 of 77 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 77 completed trials
Clinical Trials (170)
A Prospective Cohort Study on the Epidemiological Investigation, Diagnosis, and Treatment of Hepatic Encephalopathy
TReatment for ImmUne Mediated PathopHysiology
Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis
Speech in Hepatic Encephalopathy (HE)
Endoscopic Shunts Embolization for Refractory Hepatic Encephalopathy
Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE)
Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement
Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep Problems
Evaluation of the Outcome of Fecal Microbiota Transplantation
Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis
The Liver Cirrhosis Cognitive Decline Scale (LiCCoS)
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy
Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy
Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy
VICIS - Vienna Cirrhosis Study
Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis
Efficacy and Safety of Nifuroxazide in the Treatment of Hepatic Encephalopathy in Egyptian Patients With Liver Cirrhosis
Affect of Melatonin on Sleep and Cognition in Cirrhosis